Submitted by Anonymous (not verified) on 4 November 2026 - 14:15
Human medicines European public assessment report (EPAR): Brukinsa, zanubrutinib, Date of authorisation: 22/11/2021, Revision: 17, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Brukinsa, zanubrutinib, Date of authorisation: 22/11/2021, Revision: 17, Status: Authorised